In two elegant studies, Zeboudj, Ait-Oufella and colleagues demonstrated that cell-specific depletion of EGFR either in myeloid cells (119) or in CD4+ T cells (120) protected Ldlr−/− mice from atherosclerosis. The gene discussed is EGFR; the disease is atherosclerosis.